Good Life Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.83M Buy
75,425
+3,170
+4% +$76.8K 0.11% 153
2025
Q1
$1.83M Buy
72,255
+845
+1% +$21.4K 0.13% 141
2024
Q4
$1.89M Buy
71,410
+15,211
+27% +$404K 0.14% 134
2024
Q3
$1.63M Buy
56,199
+3,869
+7% +$112K 0.1% 162
2024
Q2
$1.46M Buy
52,330
+10,514
+25% +$294K 0.12% 144
2024
Q1
$1.16M Buy
41,816
+10,192
+32% +$283K 0.1% 150
2023
Q4
$910K Buy
31,624
+1,468
+5% +$42.3K 0.09% 167
2023
Q3
$1M Buy
30,156
+376
+1% +$12.5K 0.11% 153
2023
Q2
$1.09M Buy
29,780
+1,756
+6% +$64.4K 0.12% 138
2023
Q1
$1.14M Sell
28,024
-1,677
-6% -$68.4K 0.15% 124
2022
Q4
$1.52M Buy
29,701
+636
+2% +$32.6K 0.21% 103
2022
Q3
$1.27M Sell
29,065
-104
-0.4% -$4.55K 0.19% 108
2022
Q2
$1.53M Sell
29,169
-3,277
-10% -$172K 0.21% 93
2022
Q1
$1.68M Buy
32,446
+583
+2% +$30.2K 0.21% 93
2021
Q4
$1.88M Buy
31,863
+51
+0.2% +$3.01K 0.23% 84
2021
Q3
$1.37M Buy
31,812
+1,648
+5% +$70.9K 0.19% 97
2021
Q2
$1.18M Buy
30,164
+3,138
+12% +$123K 0.22% 84
2021
Q1
$975K Buy
27,026
+1,281
+5% +$46.2K 0.2% 95
2020
Q4
$947K Sell
25,745
-1,502
-6% -$55.2K 0.22% 82
2020
Q3
$949K Buy
27,247
+2,431
+10% +$84.7K 0.26% 74
2020
Q2
$773K Buy
24,816
+1,463
+6% +$45.6K 0.23% 83
2020
Q1
$724K Sell
23,353
-2,565
-10% -$79.5K 0.26% 84
2019
Q4
$971K Buy
25,918
+776
+3% +$29.1K 0.28% 71
2019
Q3
$855K Sell
25,142
-760
-3% -$25.8K 0.26% 73
2019
Q2
$1.07M Buy
25,902
+920
+4% +$38K 0.31% 56
2019
Q1
$1.01M Buy
24,982
+3,061
+14% +$123K 0.3% 58
2018
Q4
$908K Buy
21,921
+6,786
+45% +$281K 0.29% 61
2018
Q3
$633K Sell
15,135
-4,730
-24% -$198K 0.18% 98
2018
Q2
$679K Buy
19,865
+1,112
+6% +$38K 0.22% 85
2018
Q1
$625K Buy
18,753
+886
+5% +$29.5K 0.21% 81
2017
Q4
$619K Buy
17,867
+677
+4% +$23.5K 0.19% 84
2017
Q3
$588K Sell
17,190
-2,121
-11% -$72.6K 0.22% 74
2017
Q2
$615K Sell
19,311
-28
-0.1% -$892 0.27% 69
2017
Q1
$624K Buy
19,339
+3,825
+25% +$123K 0.3% 61
2016
Q4
$484K Buy
+15,514
New +$484K 0.28% 62